123 related articles for article (PubMed ID: 22706230)
1. Human cytochrome P450 4F3: structure, functions, and prospects.
Corcos L; Lucas D; Le Jossic-Corcos C; Dréano Y; Simon B; Plée-Gautier E; Amet Y; Salaün JP
Drug Metabol Drug Interact; 2012 Apr; 27(2):63-71. PubMed ID: 22706230
[TBL] [Abstract][Full Text] [Related]
2. Expression of the CYP4F3 gene. tissue-specific splicing and alternative promoters generate high and low K(m) forms of leukotriene B(4) omega-hydroxylase.
Christmas P; Ursino SR; Fox JW; Soberman RJ
J Biol Chem; 1999 Jul; 274(30):21191-9. PubMed ID: 10409674
[TBL] [Abstract][Full Text] [Related]
3. Expression and induction of CYP4F subfamily in human leukocytes and HL60 cells.
Kikuta Y; Yamashita Y; Kashiwagi S; Tani K; Okada K; Nakata K
Biochim Biophys Acta; 2004 Jul; 1683(1-3):7-15. PubMed ID: 15238214
[TBL] [Abstract][Full Text] [Related]
4. CYP4F3B expression is associated with differentiation of HepaRG human hepatocytes and unaffected by fatty acid overload.
Madec S; Cerec V; Plée-Gautier E; Antoun J; Glaise D; Salaun JP; Guguen-Guillouzo C; Corlu A
Drug Metab Dispos; 2011 Oct; 39(10):1987-96. PubMed ID: 21778351
[TBL] [Abstract][Full Text] [Related]
5. Human CYP4F3s are the main catalysts in the oxidation of fatty acid epoxides.
Le Quéré V; Plée-Gautier E; Potin P; Madec S; Salaün JP
J Lipid Res; 2004 Aug; 45(8):1446-58. PubMed ID: 15145985
[TBL] [Abstract][Full Text] [Related]
6. Myeloid expression of cytochrome P450 4F3 is determined by a lineage-specific alternative promoter.
Christmas P; Carlesso N; Shang H; Cheng SM; Weber BM; Preffer FI; Scadden DT; Soberman RJ
J Biol Chem; 2003 Jul; 278(27):25133-42. PubMed ID: 12709424
[TBL] [Abstract][Full Text] [Related]
7. Alternative splicing determines the function of CYP4F3 by switching substrate specificity.
Christmas P; Jones JP; Patten CJ; Rock DA; Zheng Y; Cheng SM; Weber BM; Carlesso N; Scadden DT; Rettie AE; Soberman RJ
J Biol Chem; 2001 Oct; 276(41):38166-72. PubMed ID: 11461919
[TBL] [Abstract][Full Text] [Related]
8. Prostaglandin and leukotriene omega-hydroxylases.
Kikuta Y; Kusunose E; Kusunose M
Prostaglandins Other Lipid Mediat; 2002 Aug; 68-69():345-62. PubMed ID: 12432928
[TBL] [Abstract][Full Text] [Related]
9. Cytochrome P450 omega hydroxylase (CYP4) function in fatty acid metabolism and metabolic diseases.
Hardwick JP
Biochem Pharmacol; 2008 Jun; 75(12):2263-75. PubMed ID: 18433732
[TBL] [Abstract][Full Text] [Related]
10. cDNA cloning and expression of a novel cytochrome p450 (cyp4f12) from human small intestine.
Hashizume T; Imaoka S; Hiroi T; Terauchi Y; Fujii T; Miyazaki H; Kamataki T; Funae Y
Biochem Biophys Res Commun; 2001 Feb; 280(4):1135-41. PubMed ID: 11162645
[TBL] [Abstract][Full Text] [Related]
11. Human leukotriene B4 omega-hydroxylase (CYP4F3) gene: molecular cloning and chromosomal localization.
Kikuta Y; Kato M; Yamashita Y; Miyauchi Y; Tanaka K; Kamada N; Kusunose M
DNA Cell Biol; 1998 Mar; 17(3):221-30. PubMed ID: 9539102
[TBL] [Abstract][Full Text] [Related]
12. A disease-associated missense mutation in CYP4F3 affects the metabolism of leukotriene B4 via disruption of electron transfer.
Smeets E; Huang S; Lee XY; Van Nieuwenhove E; Helsen C; Handle F; Moris L; El Kharraz S; Eerlings R; Devlies W; Willemsen M; Bücken L; Prezzemolo T; Humblet-Baron S; Voet A; Rochtus A; Van Schepdael A; de Zegher F; Claessens F
J Cachexia Sarcopenia Muscle; 2022 Aug; 13(4):2242-2253. PubMed ID: 35686338
[TBL] [Abstract][Full Text] [Related]
13. Expression and characterization of human cytochrome P450 4F11: Putative role in the metabolism of therapeutic drugs and eicosanoids.
Kalsotra A; Turman CM; Kikuta Y; Strobel HW
Toxicol Appl Pharmacol; 2004 Sep; 199(3):295-304. PubMed ID: 15364545
[TBL] [Abstract][Full Text] [Related]
14. Cloning and expression of a novel form of leukotriene B4 omega-hydroxylase from human liver.
Kikuta Y; Kusunose E; Kondo T; Yamamoto S; Kinoshita H; Kusunose M
FEBS Lett; 1994 Jul; 348(1):70-4. PubMed ID: 8026587
[TBL] [Abstract][Full Text] [Related]
15. Statins increase cytochrome P450 4F3-mediated eicosanoids production in human liver cells: a PXR dependent mechanism.
Plée-Gautier E; Antoun J; Goulitquer S; Le Jossic-Corcos C; Simon B; Amet Y; Salaün JP; Corcos L
Biochem Pharmacol; 2012 Aug; 84(4):571-9. PubMed ID: 22634049
[TBL] [Abstract][Full Text] [Related]
16. Expression and physiological function of CYP4F subfamily in human eosinophils.
Kikuta Y; Mizomoto J; Strobel HW; Ohkawa H
Biochim Biophys Acta; 2007 Dec; 1771(12):1439-45. PubMed ID: 17980168
[TBL] [Abstract][Full Text] [Related]
17. CYP4F3B is induced by PGA1 in human liver cells: a regulation of the 20-HETE synthesis.
Antoun J; Goulitquer S; Amet Y; Dreano Y; Salaun JP; Corcos L; Plée-Gautier E
J Lipid Res; 2008 Oct; 49(10):2135-41. PubMed ID: 18566475
[TBL] [Abstract][Full Text] [Related]
18. Gene expression of a novel cytochrome P450 of the CYP4F subfamily in human seminal vesicles.
Bylund J; Finnström N; Oliw EH
Biochem Biophys Res Commun; 1999 Jul; 261(1):169-74. PubMed ID: 10405341
[TBL] [Abstract][Full Text] [Related]
19. A novel cytochrome P450 enzyme responsible for the metabolism of ebastine in monkey small intestine.
Hashizume T; Mise M; Matsumoto S; Terauchi Y; Fujii T; Imaoka S; Funae Y; Kamataki T; Miyazaki H
Drug Metab Dispos; 2001 Jun; 29(6):798-805. PubMed ID: 11353747
[TBL] [Abstract][Full Text] [Related]
20. Catalytic activity and isoform-specific inhibition of rat cytochrome p450 4F enzymes.
Xu F; Falck JR; Ortiz de Montellano PR; Kroetz DL
J Pharmacol Exp Ther; 2004 Mar; 308(3):887-95. PubMed ID: 14634044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
